Cardiac troponin T and NT-proBNP as biomarkers of early myocardial damage in amitriptyline-induced cardiovascular toxicity in rats

International Journal of Toxicology

Volumn 32, Issue 5, 2013, Pages 351-357

  Sorodoc, Victorita ^a   Sorodoc, Laurentiu ^a   Ungureanu, Didona ^a   Sava, Anca ^a   Jaba, Irina M ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

amitriptyline; brain natriuretic peptide; cardiac troponin; cardiotoxicity; rat

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMITRIPTYLINE; BIOLOGICAL MARKER; TROPONIN T;

ACUTE TOXICITY; ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOTOXICITY; COMPUTER SYSTEM; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE NECROSIS; HEART RATE; HISTOPATHOLOGY; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT;

AMITRIPTYLINE; BRAIN NATRIURETIC PEPTIDE; CARDIAC TROPONIN; CARDIOTOXICITY; RAT;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL MARKERS; HEART; HEART DISEASES; LONG QT SYNDROME; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; TROPONIN T;

EID: 84887829785     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581813503888     Document Type: Article

References (39)

1. Wallace BK, Hausner E, Herman E, et al. Serum troponin as biomarkers of drug-induced cardiac toxicity. Toxicol Pathol. 2004 ; 32 (1). 106-121
2. Adamcova M, Sterb M, Simunek T, et al. Troponin as a marker of myocardial damage in drug-induced cardiotoxicity. Expert Opin Drug Saf.. :
3. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation. 2000 ; 102 (11). 1216-1220
4. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006 ; 48 (1). 1-11
5. Hessel MH, Michielsen EC, Atsma DE, et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol. 2008 ; 85 (2). 90-95
6. Wu AH. Biochemical markers of cardiac damage: from traditional enzymes to cardiac specific proteins. Scand J Clin Lab Invest. 1999 ; 50 ((230). 82
7. Kawakami T, Lowbeer C, Valen G, Vaage J. Post-ischemic dysfunction does not correlate with release of cardiac troponin T in isolated rat hearts. Acta Physiol Scand. 1999 ; 167 (1). 23 7
8. Thomas SA, Fallavollita JA, Lee TC, Feng J, Canty JM. Absence of troponin i degradation of altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine. Circ Res. 1999 ; 85 (5). 446 56
9. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000 ; 32 (1). 56-67
10. Kang YJ Casarett and Doull's Toxicology. The Basic Science of Poisons. Klaassen CD, ed. Blacklick, OH: The McGraw-Hill Companies, Inc ; 2008: 699-740.
11. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996 ; 93 (11). 1963-1969
12. Okumura H, Iuchi K, Yoshida T, et al. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. Acta Haematol. 2000 ; 104 (4). 158-163
13. Erkus B, Demirtas S, Yarpuzlu AA, Can M, Genc Y, Karaca L. Early prediction of anthracycline induced cardiotoxicity. Acta Paediatr. 2006 ; 96 (4). 506-509
14. Walker DB. Serum chemical biomarkers of cardiac injury for nonclinical safety testing. Toxicol Pathol. 2006 ; 34 (1). 94 104
15. Chamsi-Pasha H, Barnes PC. Myocardial infarction: a complication of amitriptyline overdose. Postgrad Med J. 1998 ; 64 ((758)). 968 70
16. Kiyan S, Aksay E, Yanturali S, Atilla R, Ersel M. Acute myocardial infarction associated with amitriptyline overdose. Basic Clin Pharmacol Toxicol. 2006 ; 98 (5). 462-466
17. Arya B, Hirudayaraj P, Willmer K. Myocardial infarction: a rare complication of dothiepin overdose. Int J Cardiol. 2004 ; 96 (3). 493 49 4
18. Zakynthinos E, Vassilakopoulos T, Roussos C, Zakynthinos S. Abnormal atrial and ventricular repolarisation resembling myocardial injury after tricyclic antidepressant drug intoxication. Heart. 2000 ; 83 (3). 353 35 4
19. Steeds RP, Muthusamy R. Abnormal ventricular conduction following dothiepin overdose simulating acute myocardial infarction. Heart. 2000 ; 83 (3). 289
20. Guthrie RM, Lott JA. Abnormal serum creatine kinase and MB fraction following an amitriptyline overdose. J Fam Pract. 1986 ; 22 (6). 554-555
21. Barrueto F, Chuang A, Cotter BW, Hoffman RS, Nelson LS. Amiodarone fails to improve survival in amitriptyline-poisoned mice. Clin Toxicol (Phila). 2005 ; 43 (3). 147-149
22. York MJ A comprehensive Guide to Toxicology in Preclinical Drug Development. 1 st ed. San Diego: Academic Press; 2013:187-203. Faji AS, ed. San Diego: Academic Press ; 2013: 187-203.
23. Crome P. Poisoning due to tricyclic antidepressant overdosage: clinical presentation and treatment. Med Toxicol. 1985 ; 1 (4). 261-285
24. Kalkan S, Hocaoglu N, Arici AA, Oransay K, Ergor G, Tuncok Y. Effects of adenosine receptor antagonists on survival in amitriptyline-poisoned mice. Drug Chem Toxicol. 2010 ; 33 (3). 233-237
25. Flecknell P Laboratory Animal Anaesthesia. 2 nd. ed., London, UK: Elsevier Academic Press; 1996:161-168. London, UK: Elsevier Academic Press ; 1996: 161-168.
26. Rutkowska A, Piekoszewski W, Brandys J. Chronopharmacokinetics of amitriptyline in rats. Biopharm Drug Dispos. 1999 ; 20 (3). 117-124
27. Mayo PR, Jamali F. Methoxyflurane anesthesia augments the chronotropic and dromotropic effects of verapamil. J Pharm Pharm Sci. 1999 ; 2 (1). 30 5
28. Kumar S, Kela AK, Mehta VL, Shukla AK. Preferred anaesthetic agents in experimental cardiology: a study on rat electrocardiogram. Indian J Pharmacol. 1995 ; 27 (2). 127-129
29. Bertinchant JP, Robert E, Polge A, et al. Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta. 2000 ; 298 (1-2). 13-28
30. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem. 2001 ; 38 (pt 5). 423 49
31. Stiegler H, Fischer Y, Vazquez-Jimenez JF, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem. 2000 ; 46 (9). 1338-1344
32. Reagan JW. Troponin as a biomarker of cardiac toxicity. past, present, and future. Toxicol Pathol. 2010 ; 38 ((7 )). 1134-1137
33. Fredericks S, Merton GK, Lerena MJ, Heining P, Carter ND, Holt DW. Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta. 2001 ; 304 (1-2). 65-74
34. Lum G, Solarz DE, Farney L. False positive cardiac troponin results in patients without acute myocardial infarction. Lab Med. 2006 ; 37 (9). 546-550
35. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest. 2004 ; 125 (5). 1877-1884
36. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006 ; 92 (7). 987-993
37. Azkarate E, Luque Lezcano O, Lara, Bocero G, Cabarcos Grávalos E. Electrocardiographic alterations mimicking ischemic heart disease in a patient with tricyclic antidepressive poisoning. Med Intensiva. 2007 ; 31 (3). 159
38. Bolognesi R, Tsialtas D, Vasini P, Conti M, Manca C. Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol. 1997 ; 79 (2). 242-242
39. Hori Y, Ohshima N, Chikazawa S, et al. Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury. Vet J. 2012 ; 191 (1). 46-51